Clinical Trials Logo

Type 2 Diabetes clinical trials

View clinical trials related to Type 2 Diabetes.

Filter by:

NCT ID: NCT00960076 Completed - Type 2 Diabetes Clinical Trials

An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes

SCORE
Start date: August 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare reduction in A1C for subjects taking Saxagliptin and Metformin XR vs. uptitrated Metformin XR.

NCT ID: NCT00956735 Completed - Type 2 Diabetes Clinical Trials

Effects of Pistachios on Cardiovascular Responses to Stress in Type 2 Diabetes

Pistachio
Start date: August 2009
Phase: N/A
Study type: Interventional

This study is investigating the effects of three different diets, including a diet with pistachios, on cardiovascular disease risk markers in people with type 2 diabetes.

NCT ID: NCT00955747 Completed - Type 2 Diabetes Clinical Trials

Naturlose (D-Tagatose) Efficacy Evaluation Trial

NEET
Start date: April 2007
Phase: Phase 3
Study type: Interventional

The purpose of this trial was to evaluate the effectiveness and safety of Naturlose (Tagatose) for glycemic control in people with Type 2 diabetes who were not taking other medications for the condition and who were under diet control and exercise. The study lasted approximately one year. HbA1c was monitored every 2 months after entry into the study. Safety and tolerance for tagatose were assessed every 2 months throughout the study. A total of 14 visits were made to the study site.

NCT ID: NCT00954577 Recruiting - Type 2 Diabetes Clinical Trials

Reduce Obesity and Diabetes

ROAD
Start date: July 2006
Phase: N/A
Study type: Observational

This study examines risk factors for type 2 diabetes in children representing multiple discrete ethnic groups. It also examines the short term effects of school-based health education supervised exercise on metabolic risk factors for type 2 diabetes mellitus in children. The investigators hypothesize that exercise and health education will significantly improve insulin sensitivity in all children, especially in children who are already insulin resistant, thereby lowering the risk that they will go on to develop type 2 diabetes mellitus. The specific hypotheses being tested are: 1. Insulin resistance will be most evident in overweight children while an impaired ability of the pancreas to release insulin will be most evident in children with a family history of type 2 diabetes mellitus. 2. Exercise will significantly improve insulin resistance (as measured by the fasting glucose/insulin ratio) with little effect on insulin secretory capacity in children. 3. Participation in a school-based health, nutrition, and exercise education program will have long term beneficial effects on health related behaviors and on insulin resistance in all children, regardless of their level of diabetes risk.

NCT ID: NCT00953498 Completed - Type 2 Diabetes Clinical Trials

Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins

Start date: October 2007
Phase: Phase 4
Study type: Interventional

HDL from patients with type 2 diabetes show a significant reduction of their endothelium-dependent vasodilatory effect. The primary objective of the study is to analyze whether treatment with glitazones (pioglitazone and rosiglitazone)may improve the endothelium-dependent vasodilatory effect of HDL lipoproteins in patients with type 2 diabetes. The secondary objectives are: - to analyze the effect of glitazone treatment on phospholipase A2 - to look for possible differences between the effects of pioglitazone and those of rosiglitazone - to analyze the glycemic response to glitazone therapy according to clinical and biological baseline characteristics.

NCT ID: NCT00952198 Completed - Type 2 Diabetes Clinical Trials

A Safety Study of ARRY-403 in Patients With Type 2 Diabetes

Start date: August 2009
Phase: Phase 1
Study type: Interventional

This is a Phase 1 study, involving a 10-day dosing period, designed to test the safety of investigational study drug ARRY-403 (as monotherapy or in addition to stable metformin therapy) in patients with Type 2 diabetes. Approximately 128 patients from the US will be enrolled in this study.

NCT ID: NCT00951899 Completed - Type 2 Diabetes Clinical Trials

The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics

Start date: August 2009
Phase: Phase 4
Study type: Interventional

The goal of this study was to determine the metabolic mechanism for a certain type medication's ability to lower blood sugar after a meal in Type 2 Diabetics, in order to develop a better understanding of it's potential role in the treatment of obesity.

NCT ID: NCT00950963 Completed - Type 2 Diabetes Clinical Trials

Nurse Telephone Management of Cholesterol in Diabetes

NATCHOS
Start date: September 2005
Phase: N/A
Study type: Interventional

The current project is evaluating the effect of a nurse-administered phone care in diabetes to improve access to care and healthcare delivery. The setting is a federally qualified community health center serving over 1600 diabetic patients, 80% of whom are Latino. Using our diabetes registry, we have randomly assigned 762 patients to either participate in a telephone-based, nurse-run outreach program (N=381) or to continue with usual care(N=381). Three of our registered nurses learned algorithms addressing management of cholesterol, blood pressure, kidney disease, aspirin use, eye screening, and pneumovax and influenza vaccines. The program began recruitment in September 2005 and has finished follow up in May 2007. The program initially focused only on cholesterol management utilizing national guidelines and algorithms on patients with elevated cholesterol (LDL) levels but has expanded to include glycemic and blood pressure control. We found that Registered Nurses were able and willing to provide telephone care to diabetic patients according to moderately complex algorithms and to track patient data electronically with overall job satisfaction. Overall, the nurses have expressed enthusiasm but have also experience frustrations with maintaining contact and improving motivation in patients. The impact of this program on diabetes outcomes and its cost-effectiveness is currently being analyzed with the goal of implementing this program in our institution.

NCT ID: NCT00950898 Completed - Type 2 Diabetes Clinical Trials

The Acute Effects of Coffee on Glucose Metabolism

Start date: November 2006
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the acute effects of decaffeinated coffee, caffeinated coffee and caffeine on glucose metabolism in humans

NCT ID: NCT00950677 Completed - Type 2 Diabetes Clinical Trials

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

T2DM
Start date: July 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to see if giving study drugs before a meal may lower blood sugars after the meal. An improvement in blood sugar control may prevent long-term problems of diabetes.